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Background: In this study, it was determined that BKV is shed in saliva and an in vitro model system was
developed whereby BKV can productively infect both submandibular (HSG) and parotid (HSY) salivary gland
cell lines.
Results: BKV was detected in oral ﬂuids using quantitative real-time PCR (QRTPCR). BKV infection was
determined using quantitative RT-PCR, immunoﬂuorescence and immunoblotting assays. The infectivity of
BKV was inhibited by pre-incubation of the virus with gangliosides that saturated the major capsid protein,
VP1, halting receptor mediated BKV entry into salivary gland cells. Examination of infected cultures by
transmission electron microscopy revealed 45–50 nm BK virions clearly visible within the cells. Subsequent
to infection, encapsidated BK virus was detected in the supernatant.
Conclusion: We thus demonstrated that BKV was detected in oral ﬂuids and that BK infection and replication
occur in vitro in salivary gland cells. These data collectively suggest the potential for BKV oral route of
transmission and oral pathogenesis.
© 2009 Elsevier Inc. All rights reserved.Background
BK virus (BKV) belongs to the polyomavirus family and is
ubiquitous in the human population (Fields et al., 2007). The viral
capsid is icosahedral and has a diameter of 45–50 nm. The genome
consists of a closed circular double-stranded DNA molecule with
approximately 5 kb. BKV genome consists of an early region, a late
region and a regulatory region (RR) containing promoters, enhancers
and the replication origin. The genome is transcribed bi-directionally
from the origin, with the early region encoding for two non-structural
proteins: large tumor antigen (T Ag), and small tumor antigen (t Ag).
The late region encodes for structural capsid proteins VP1, VP2 and
VP3 and the non-structural agnoprotein (Fields et al., 2007). BKV
initially binds to its cell surface receptor, an N-linked glycoprotein or
ganglioside GD1b or GT1b, all of which contain an α(2,3)-linked sialic
acid residue (Dugan et al., 2007; Low et al., 2006) and is caveolae-
mediated endocytosed and trafﬁcs to the nucleus via the endoplasmic
reticulum (Dugan et al., 2006). Viral uncoating is believed to occur
within tubulo-reticular structures at the nuclear periphery prior to
nuclear entry (Drachenberg et al., 2003; Dugan et al., 2006). Once in
the cell nucleus, the uncoated chromosome is transcribed. Early geneUniversity of North Carolina,
3.
riaque@dentistry.unc.edus
ll rights reserved.transcription products result in T antigens that cause quiescent cells to
re-enter the cell cycle and increase cellular growth and proliferation.
In permissive host cells the T antigens, acting as regulatory proteins,
direct the remaining events, resulting in a productive infection. The
completion of the process consists of viral DNA replication and
transcription of late genes for the production of the structural proteins
(VP1, VP2 and VP3) that constitute the capsid (Dugan et al., 2006;
Eash et al., 2004; Fields et al., 2007; Hirsch and Steiger, 2003; Low
et al., 2004). Viral capsomeres assemble around the daughter
chromosomes in the nucleus, to form stable viral particles. Viral
egress is thought to occur via cell lysis, although virions have been
detected within vesicles in the cytoplasm (Drachenberg et al., 2003).
BKV infection typically occurs during childhood, without speciﬁc
symptoms, followed by a state of non-replicative infection in various
tissues, with the urogenital tract as the principal site (Hirsch, 2005). In
the setting of relative or absolute cell-mediated immunosuppression,
dramatic increase in BK viral replication occurs, resulting in the lytic
destruction of infected uroepithelial cells, which in turn induces the
inﬂux of inﬂammatory immune cells (Hirsch, 2002). This destruction
of kidney cells most often occurs in 5–8% of kidney transplants
resulting in organ loss in half of these cases and is termed BKV-
associated nephropathy (BKVN) (Dugan et al., 2006; Hirsch and
Steiger, 2003; Nickeleit et al., 2000). Rise in the incidence of
Polyomavirus viruria and viremia has been detected in recipients of
bone marrow, kidney and heart transplants, as well as an increase in
viruria in HIV-infected individuals (Eash et al., 2006). The potential for
Fig. 1. BKV DNA detection in oral ﬂuids. BKV DNA levels in the saliva were measured by
real-time PCR andwere found to be signiﬁcantly higher in patients diagnosed with HIV-
associated salivary gland disease compared to patients without the disease. BKV levels
in persons with HIV-SGD ranged from 101 to 104 copies/ml while non-diseased persons
ranged from 10−2 to 102 copies/ml. pb0.0001.
184 L.K. Jeffers et al. / Virology 394 (2009) 183–193BK replication at distant sites such as the salivary gland may certainly
exist in the setting of HIV infection (Eash et al., 2006; Webster-
Cyriaque, personal communication).
While it is clear that BKV infection is an ubiquitous childhood
infection, BKV transmission is not currently well understood. The
present studies were undertaken to determine whether BKV could
infect and replicate within salivary gland cells resulting in virus
production and potentially transmission.We have detected BKV in the
saliva of patients with HIV-associated salivary gland pathology and in
healthy individuals. In order to begin to decipher BKV pathogenesis
within the salivary gland cell it was essential to develop an in vitro
model system. We have chosen to characterize BKV infection inFig. 2. Detection of BK virions in salivary gland cell lines infected with BKV. (A) HSG and Ver
labeled BSA (green) or Alexa-Fluor 488-labeled 1X PBS (data not shown) as stated in the Ma
observed by confocal microscopy using a 63× lens objective. At 24 hpi, labeled BKV (green) w
cells. At 48 hpi, labeled BKV (green) was detected at the perinuclear region of HSG cells and
detected only in the extracellular regions of both HSG and Vero cells. TO-PRO3 dye was usedsubmandibular (HSG) and parotid (HSY) gland cell lines. These cells
were able to support viral entry, transcription, translation and virion
production and BKV infection could be inhibited by saturating the
capsid protein with its ganglioside receptor.
Results
BKV DNA detection in oral ﬂuids
Salivary shedding of BKV was assessed in a small cohort of healthy
and immune suppressed individuals who had HIV disease. The mean
BK copy number in saliva from individuals with HIV and an associated
salivary gland disease was 3644 (n=11). HIV negative individuals
had mean BK copy numbers that were signiﬁcantly less at 26 (n=7)
(Fig. 1).
BK virions enter human salivary gland cells
To determine whether BKV could enter salivary gland cells in vitro
virion labeling was employed (Fig. 2). Fig. 2 shows CsCl puriﬁed BKV
labeled with Alexa-Fluor™ 488 (green) and the stained nucleus (red).
Bovine serum albumin (BSA) and 1× PBS (data not shown) were also
labeled with Alexa-Fluor™ 488 as positive and negative labeling
controls, respectively. HSG or Vero cells were incubated with BKV at
64 HAU for 24 h, washed and ﬁxed. Using confocal visualization, at
24 h BKV particles were located in the cell cytoplasm of both HSG and
Vero cells. At 48 h BKV accumulation was detected at the perinuclear
region of HSG cells. This type of perinuclear accumulation has
previously been described in human kidney cells in vivo (Drachen-
berg et al., 2003) and in vitro (Moriyama and Sorokin, 2008). We did
not observe perinuclear accumulation of virions in Vero cells at theo cells were infected with Alexa-Fluor 488-labeled BK virus (green) or Alexa-Fluor 488-
terials and methods. At stated times post-infection, monolayers of cells were ﬁxed and
as detected at the plasma cell membrane of HSG cells and within the cytoplasm of Vero
not at all detected in Vero cells. Labeled BSA (green) and 1× PBS (data not shown) was
to stain the cell nuclei (red). White arrows point to Alexa-Fluor 488-labeled BK virions.
185L.K. Jeffers et al. / Virology 394 (2009) 183–19348 h time point suggesting that viral uncoating and nuclear entry may
have already occurred. It has previously been shown in human kidney
cells that BKV trafﬁcs from the cell surface to the nucleus within 12 to
24 h (Moriyama and Sorokin, 2008) which may explain our inability
to detect labeled BKV at the stated 48 h time point in Vero cells. The
kinetics of entry and uncoating may be cell type speciﬁc.
BKV transcripts expressed in salivary gland cells
Upon determination of BKV entry into salivary gland cells in vitro,
the outcome of infection was assessed. Viral transcription levels of
early gene, T Ag and the late gene, VP1 were examined. In both
submandibular (HSG) and parotid gland (HSY) cell lines an increase in
viral transcription of both T Ag and VP1 genes was observed up to
6 dpi (Fig. 3). Beyond 6 dpi, cells became over-conﬂuent, lifted off of
the plate surface and began to die. A steady increase in transcription of
both T Ag and VP1 transcripts was detected, generally peaking at
3 dpi. We consistently observed higher levels of VP1 versus T Ag
transcripts in both cell types. This is consistent with the requirement
for increased amounts of structural protein as compared to non-
structural protein for viral replication to occur. Small amounts of T Ag
are necessary to activate late gene transcription. Results were
normalized to the levels of β-actin, using the 2−C(T) method, and
are presented as the changes (n-fold) in T Ag and VP1 transcript
levels. Uninfected, mock samples were arbitrarily set to 1.
BKV protein expression in salivary gland cells
Translation of T Ag in BKV-infected HSG cells was assessed by
immunoblotting and immunoﬂuorescence techniques (Figs. 4A, B and
C). As expected protein expression was delayed compared to mRNAFig. 3. BKV replicates in human salivary gland cells. HSG and HSY cells were infected with BK
post-infection cells were collected, RNA isolated, cDNA generated and quantitative real-t
normalized to the levels of β-actin transcripts, using the 2−C(T) method, and are presented a
mock samples arbitrarily set to 1.transcription, consistent with previous work showing that BK virus
replicates slowly in vitro (Dugan et al., 2006; Low et al., 2004;
Moriyama and Sorokin, 2008). Nuclear T Ag and VP1 protein
expression was ﬁrst detected at 4 dpi by IFA (Fig. 4B and 4A). Based
on counting of IF positive cells at 5 dpi (data not shown), an average of
ten experiments determined the percentage of VP1 positive cells was
approximately 15% and the percentage of T ag positive cells were 10%
or less. Immunoblot consistently detected expression of both small
and large T antigen at 4 dpi, although in one infection small amounts
of protein were detected at day 3 (Fig. 4C top and middle panel).
Collectively, these data indicate that BKV gene expression occurred in
human salivary gland cells in vitro.
Salivary gland cells release infectious virus into the supernatant
In order to determine whether BKV infection of salivary gland cells
results in productive infection, release of infectious virions from
salivary gland cells was assessed. BK virions were not detected by
electron microscopy in salivary gland cells days 2–4 dpi. However, at
5 dpi 45–50 nm BK virions were identiﬁed within the cell cytoplasm
similar to those virions detected within BKV-infected kidney cells
(decoy cells) shed into the urine of a kidney transplant patient
diagnosed with BKV nephropathy (Fig. 5). No viral particles were
detected prior to 5 dpi within the cell cytoplasm.
Time courses were performed during which supernatants from
HSG cells were collected and ﬁltered at 0, 1, 3, 4 and 5 days post-
infection. Two separate experiments were performed in which 1)
separate plates were infected and harvested at stated time points
(data not shown) or 2) a single plate was infected from which
supernatant was collected over time (Fig. 6). Supernatants were then
DNAse/Proteinase K treated to detect only encapsidated viral DNAV or media alone (mock) as described in the Materials and methods. (A) At stated times
ime PCR performed for T Ag and VP1 viral transcripts. Gene expression values were
s the changes (n-fold) in T Ag and VP1 transcript levels, with the levels in uninfected/
Fig. 4. At 4 dpi, monolayer of cells were ﬁxed and probed for (A) T Ag and (B) VP1 expression using PAb 416 and NCL-JCBK antibodies, respectively. Photos are representative BKV-
infected (top andmiddle panel) or control mock (bottom panel) HSG cells stained for T Ag (green) and VP1 (green). DAPI (blue) was used to stain the cell nuclei and Brefeldin A (red)
used to stain the endoplasmic reticulum. (×20 magniﬁcation). (C) At stated times post-infection cell lysates were collected and used for immunoblotting as described in the
Materials and methods. Antibodies against T Ag (top panel) and β-actin (bottom panel) were used. T Ag protein was ﬁrst detected at 4 dpi.
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Fig. 4 (continued).
Fig. 6. Encapsidated BK virions released from human salivary gland cells. Supernatant of
BKV ormock (media only) infected HSG cells was collected at 0, 1, 3, 4 and 5 dpi, ﬁltered
and treated with either proteinase K only to quantify total vDNA (data not shown) or
DNase followed by proteinase K treatment, to quantify encapsidated vDNA only, as
described in the Materials and methods. Eluted vDNA was then used to quantify T Ag
copy number using real-time PCR analysis. A standard curve (data not shown) was
constructed using a plasmid coding for BKV T Ag to determine copy number.
187L.K. Jeffers et al. / Virology 394 (2009) 183–193(vDNA) or Proteinase K-only treated as a control to detect both
encapsidated and unencapsidated vDNA (data not shown), as
previously described (Dugan et al., 2007). Over time post-infection
increasing levels of virus were detected by quantitative real-time PCR
indicating release of encapsidated viral DNA from infected cells.
The supernatants from HSG cells were also used to infect naive
Vero cells. At 5 days post Vero cell treatment, cells were collected for
quantitative real-time PCR, immunoﬂuorescence, and immunoblot-
ting. Again, real-time results were normalized to the levels of β-actin
transcripts using the 2−C(T) method, and are presented as the
changes (n-fold) in T Ag and VP1 transcript levels, with the levels in
mock-treated samples arbitrarily set to 1. The level of T Ag and VP1
viral transcripts, was signiﬁcantly higher in Vero cells treated with
BKV-infected HSG supernatant over mock-infected HSG supernatant
(Fig. 7A). Immunoﬂuorescence and immunoblotting techniquesFig. 5. Representative transmission electron micrograph (TEM) of BK virions at ×160,000 m
virions from BKV-infected kidney cells (decoy cells) in the urine of a BKV-associated nephrdetected T Ag protein expressed in Vero cells treated with BKV-infected
HSG supernatant (Figs. 7B and C). These data suggest that human
salivary gland cells can indeed be productively infected with BK virus.
BKV infects salivary gland cells via gangliosides
It has previously been shown that BKV's receptors include an N-
linked glycoprotein with α(2,3)-linked sialic acid and gangliosides,
GD1b and GT1b (Dugan et al., 2005; Low et al., 2006). As HSG cellsagniﬁcation of BKV and mock-infected HSG cells (top panel) at 5 dpi. Bottom panel, BK
itis patient.
Fig. 7. Infectious virus released fromHSG cells. Supernatant of BKV or media only (mock) infected HSG cells was collected at 5 dpi, ﬁltered and used to infect Vero cells as described in
the Materials and methods. At 5 days post treatment with HSG supernatant, Vero cells are examined for BKV infection by (A) quantitative real-time PCR analysis (B)
immunoﬂuorescence and (C) immunoblot. (A) For real-time PCR analysis, gene expression values were normalized to the levels of β-actin transcripts, using the 2−C(T) method, and
are presented as the changes (n-fold) in T Ag and VP1 transcript levels, with the levels in uninfected/mock samples arbitrarily set to 1. (B) Vero cells were ﬁxed at day 5 dpi and
stained for T Ag (green). DAPI (blue) was used to stain the cell nuclei. Representative photograph of BKV T Ag and nuclear staining are shown for BKV-infected and control mock Vero
cells. (C) Immunoblot analysis of Vero cells for BKV T Ag (upper panel) and β-actin (lower panel) proteins detected at 5 days post HSG supernatant treatment.
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receptor-mediated BKV entry into these cells was assessed. A mixture
containing all of these gangliosides in addition to GM1 and GD3 was
utilized as the receptor for BKV on salivary gland cells was unknown.
BKV was pre-incubated with GM1, GD1b, GT1b and GD3 to bind and
saturate the capsid protein, VP1. Two different concentrations of
ganglioside: 60 µg/ml and 100 µg/ml, were pre-incubated with BK
virus prior to infection of HSG and Vero cells. Using real-time
quantitative PCR, a 28-fold decrease was detected in viral transcrip-tion of T Ag in HSG cells infected with both BKV/60 µg and BKV/
100 µg ganglioside mix compared to cells infected with BKV/DMSO
alone. A 273-fold and 72-fold decrease was detected in Vero cells
infected with BKV/60 µg and BKV/100 µg, respectively (Fig. 8A). For
VP1 viral transcripts in HSG cells we observed a 46 and 81-fold
decrease in BKV/60 µg and BKV/100 µg ganglioside mix, respectively,
compared to cells infected with BKV/DMSO alone. In Vero cells we
detected a 402 and 62-fold decrease in VP1 transcripts when infected
with BKV/60 µg and BKV/100 µg ganglioside mix, respectively.
189L.K. Jeffers et al. / Virology 394 (2009) 183–193A decrease in the number of T Ag expressing cells was also detected
by IFA upon infection with the BKV/ganglioside mix versus cells
exposed to BKV/DMSO (Fig. 8B). In HSG cells, at 4 dpi, a 75% decrease
in T Ag expressing cells was detected with the BKV/100 µg gang-
liosideinfection (data not shown) and a 45% decrease detected with
BKV/60 µg ganglioside infection (Fig. 8B). While at 6 dpi, we observed
61% and 96% percent decrease in BKV/60 µg and BKV/100 µg infections,
respectively (Datanot shown). InVero cells, at4 (Fig. 8C)and6dpi (Data
not shown), a100% decreasewas detectedwith both the BKV/60 µg and
BKV/100 µg ganglioside infections. These data indicate that human
salivary gland cells are infected with BKV via receptor-mediated VP1
entry and suggest that there may be a difference in receptor abundance
between salivary gland cells and kidney cells.
Discussion
The present data demonstrate for the ﬁrst time, BKV detection in
saliva and evidence that human salivary gland cells can be
productively infected with BK virus. This suggests that while
kidney/uroepithelial cells have long been known to be a site of BKV
replication and latency, the salivary gland may also constitute an
infectious reservoir for BKV. Although the natural route of BKV
transmission has not been resolved (Fields et al., 2007; Hirsch, 2005),
our studies suggest a potential for oral BKV transmission.
Previous studies have investigated the presence of BKV DNA by
polymerase chain reaction (PCR) in saliva from HIV-immunodeﬁcient
individuals and healthy controls but were not detected in their cohort
(Sundsfjord et al., 1994). Our studies however, using quantitative
real-time PCR analysis detected BKV DNA in saliva samples from HIV
positive patients and healthy controls. And like most opportunistic
pathogens, BKV DNA was detected in the saliva at higher levels in
immunocompromised patients compared to healthy individuals.
The detection of labeled BK virions within the cytoplasm of
salivary gland cells conﬁrmed BKV entry. In salivary gland cells,
labeled virus was still detected at 48 hpi while labeled virus was no
longer detected in Vero cells at the same time point perhaps due to
viral uncoating and entry into the nucleus. Viral gene products were
ﬁrst observed at 24 hpi for both T Ag and VP1 using real-time RT-PCR,
with viral transcription peaking at about 3 dpi for both submandibular
and parotid gland cell infection. Protein expression was ﬁrst detected
at 4 dpi by immunoblot and IFA. While BKV transcripts were detected
in abundance the expression of viral encoded proteins was more
modest. The difference in mRNA versus protein levels may reﬂect the
decreased stability of the BKV T Ag protein. Productive infection was
further substantiated by the detection of virions by EM at 5 days post-
infection, as well as the presence of DNAse resistant virus in the
supernatant. These virions increased over time and were used to
infect naïve Vero cells. Interestingly, the kinetics of infection appeared
to be slower in salivary gland cells than in kidney cells.
BKV entry into salivary gland cells was inhibited by blocking VP1
via ganglioside saturation, as has previously been shown in Vero cells
(Sinibaldi et al., 1990). As expected viral transcription was more
signiﬁcantly diminished in the presence of 100 µg/ml ganglioside
compared to 60 µg/ml in the salivary gland cells. Similar trends were
observed in the Vero cell line upon ganglioside treatment. Likewise a
consistent decrease in viral protein expression was detected with
ganglioside treatment in both salivary gland and Vero cells.
The high incidence of BKV infection in the world population raises
obvious questions about the mode of transmission from one
individual to another. Given the known latency of the virus in the
kidney, urine would appear to be a natural vehicle for spread within
and between families. However, a variety of laboratory techniques
have been used to assess the prevalence of viruria in the pediatric age
groups, resulting in very low yield varying from 4% to 26.7% (Knowles,
2001). Transplacental transmission of BKV from mother to fetus has
also been evaluated (Coleman et al., 1980; Pietropaolo et al., 1998;Shah et al., 1980; Taguchi et al., 1975). The data thus far however is
controversial, with one group demonstrating 50% of their infants
expressing BKV-speciﬁc IgM antibodies in infants whose mothers
seroconverted during pregnancy (Pietropaolo et al., 1998; Taguchi
et al., 1975). While others have shown consistently negative results
for BKV-speciﬁc IgM in neonatal and cord blood samples drawn from
the offspring of mothers excreting viral inclusion bearing cells in the
urine (Shah et al., 1980). Transplacental transmission of polyoma-
virus has been demonstrated in mice (McCance and Mims, 1977),
and it is conceivable that the same could occur in man. BKV DNA has
also been detected in feces, blood, semen, genital tissues, peripheral
blood mononuclear cells (PBMC), and normal skin biopsies, hence it
is possible that the virus maybe transmitted by intimate contact with
infected individuals (Boﬁll-Mas et al., 2000; Chatterjee et al., 2000;
Monini et al., 1995).
The possibility of feco-oral transmission has recently been raised
upon the detection of BKV DNA in urban sewage (Boﬁll-Mas et al.,
2000). This possibility may also be considered as potentially
complementary to our studies because swallowed material passes
the mouth and nasopharynx and viruses transmitted through the
oral–fecal route may be able to multiply in the throat, for example, in
the salivary glands or tonsils. Additionally, both BKV and SV40 have
been detected in the tonsils of immunocompetent children (Patel et
al., 2008) and BKV detected in the nasopharyngeal aspirates of
children with acute respiratory tract disease (Goudsmit et al., 1982;
Patel et al., 2008; Sundsfjord et al., 1994). Again, consistent with our
studies indicating that BKV is present in the oral cavity and is possibly
amode of transmission from human to human. The presence of BKV in
the saliva and its ability to replicate in salivary glands cells in vitro
further suggests a role for oral transmission since BKVwas detected in
the saliva of both healthy and diseased patients in our study.
Conclusion
In conclusion, we have detected BKV in oral ﬂuids and have
shown that BKV is capable of permissive infection of salivary gland
cells in vitro. To our knowledge these studies provide the ﬁrst
analysis of BKV salivary gland infection and replication. To the extent
that parotid (HSY) and submandibular gland (HSG) cells can sustain
low levels of BKV replication, substantiates BKV's presence in oral
ﬂuids originating within these glandular cells and conﬁrms the
potential for BKV oral transmission. These data may provide a
foundation critical for further understanding BKV infection and
pathogenesis. The experiments described in this paper deﬁne a
system in which BKV lytic replication can be studied in vitro using a
physiologically relevant cell type. The characterization of BKV
infection of these cells sets the groundwork for future studies to
better understand how BKV is able to persist within the human host
and reactivate under immuno-suppressed conditions. Further studies
will help us to identify factors that inﬂuence the vulnerability of
salivary gland epithelial cells to BKV infection and more fully deﬁne
BKV's role in disease. Determination of the cellular pathways that are
altered may allow us to target and implement appropriate interven-
tions that would decrease the morbidity associated with BKV-
associated salivary gland pathologies.
Materials and methods
Patients and sample collection
HIV positive patients from UNC hospital's dental clinic/infectious
disease clinic and healthy volunteers were recruited to participate in
the IRB approved study (04-DENT-356). Five-milliliter saliva samples
from HIV positive and negative individuals were collected, contents
centrifuged and pelleted and DNA extracted by Qiagen DNeasy kit
according to the manufacturers' instruction.
Fig. 8. Inhibition of BKV infection in salivary gland cell lines via gangliosides. HSG and Vero cells were infected with BKV in the absence or presence of a ganglioside mix or
negative control media only (mock) and analyzed for T Ag expression at stated times post-infection. (A) Real-time RT-PCR analysis of T Ag (top panel) and VP1 (bottom panel)
transcripts from HSG (white bar) and Vero (checkered bar) cells at 4 dpi. Two concentrations of ganglioside mixtures were used, 60 µg/ml or 100 µg/ml, to incubate with BKV
prior to infection. Gene expression values were normalized to the levels of β-actin transcripts, using the 2−C(T) method, and are presented as the changes (n-fold) in T Ag/VP1
transcript levels, with the levels in uninfected/mock samples arbitrarily set to 1. Shown is a representative experiment, this study was performed three times in duplicate.
(B) Immunoﬂuorescence analysis of T Ag protein expression from HSG (top panel) and (C) Vero (bottom panel) cells. At 4 and 6 dpi (data not shown) monolayer of cells
were ﬁxed and stained for T Ag (green) and DAPI (blue) used to stain the cell nuclei representative photos of IFA staining for T Ag in HSG and Vero cells at 4 dpi treated with 60
ug/ml ganglioside mix. (×20 magniﬁcation).
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191L.K. Jeffers et al. / Virology 394 (2009) 183–193Cell culture and virus
HSY cells are a neoplastic epithelial cell line initially established in
culture from a human parotid gland adenocarcinoma (Hayashi et al.,
1987). HSG cells are an epithelial cell line isolated by using tissue
culture techniques from an irradiated human submandibular salivary
glandwhich showed no neoplastic lesion (Shirasuna et al., 1981). HSG
and HSY cells were obtained as a gift from Dr. B. Baum (NIH) and
cultured in McCoy's 5A medium (Sigma) and Dulbecco's minimal
essential medium (DMEM; Sigma), respectively. African monkey
kidney cells or Vero cells (American Type Culture Collection [ATCC])
were also cultured in DMEM (Sigma). All cell types were grown in
medium supplemented with 10% fetal bovine serum (FBS) (Sigma),
and 1% penicillin–streptomycin (pen/strep)(Gibco) unless otherwise
stated and maintained in a humidiﬁed 37 °C, 5%CO2 chamber. BKV
stocks were initially propagated in Vero cells from virus obtained
from ATCC (VR-837). Viral lysates were made through three cycles of
freezing the infected cells and supernatant at−80 °C and thawing at
37 °C.
Hemagglutination assay
BK virus was titered using hemagglutination assay as previously
described (Raptis, 2001). Brieﬂy, 90 µl of culture ﬂuid was added to
10 µl of 2.5% NP-40 in PBS and incubated at 37 °C for 30 min. Two-fold
dilutions of the treated-ﬂuid in 25 µl volume of HA buffer was
transferred into V-bottomed 96-well microtiter plates and 25 µl of a
cold 0.5% suspension of guinea pig erythrocytes was added to each
well. Plates were then incubated at 4 °C for non-agglutinated cells to
settle (about 2 h). BK viral titer was taken to be the highest dilution in
which N75% of the erythrocytes is agglutinated.
Conditions of infection
HSY, HSG and Vero cell monolayers were trypsinized, washed and
resuspended in fresh culture medium supplemented with 2% FBS and
1% pen/strep and plated in poly-L Lysine coated 8-well chamber slides(Falcon), 12 well dishes or 35-mm diameter well culture plates at a
concentration of 6.5×105 cells/ml. 64 HAUs of BKVwas then added to
the dish and allowed to infect for 24 h. At 24 h post-infection (hpi),
virus was removed from the culture medium, cells were washed with
1× PBS and replaced with fresh medium. The infection of HSG and
Vero cells was blocked by pre-incubation of BKV with 60 µg/ml or
100 µg/ml puriﬁed mixed gangliosides (Matreya, LLC) in media for
2–6 h at 37° C. At various times post-infection the cell monolayers or
supernatant were further processed for IFA, protein, RNA or DNA
isolation, as described below.
Indirect immunoﬂuorescence (IFA)
At stated times post-infection, cells were ﬁxed for 10 minwith 50%
methanol/50% acetone, dried at RT then incubated at −20° C
overnight for antigen retrieval. Fixed cells were then thawed at RT,
rehydrated with 1× PBS/TritonX and incubated with PAb416
(Genetex) antibody (1:30) speciﬁc for SV40T antigen. PAb416 has
been shown to cross react with BKV T antigen and is commonly used
for BKV T Ag detection. NCL-JCBK (Novocastra) antibody (1:20) was
used to detect BKV VP1 protein. NCL-JCBK is speciﬁc for both BK and JC
VP1 protein detection. Both antibodies were incubatedwith ﬁxed cells
for 1 h at 37° C followed by a ﬂuorescein-conjugated anti-mouse
(Sigma) antibody (1:20). DAPI (Invitrogen) (1:10,000) was used to
stain the nucleus and brefeldin A, BODIPY 558/568 conjugate to stain
the endoplasmic reticulum (Invitrogen). At least ten random ﬁelds of
positively stained cells were counted to determine percent infection.
Nikon FXA with Q camera or Olympus IMT2 ﬂuorescent microscopes
were used to take photographs of cells.
Immunoblotting
Total cell protein was extracted using 1% SDS lysis buffer (1% (w/v)
SDS, 0.05 M Tris Cl pH8, 1 mM DTT). Protein concentrations were
determined using the BioRad protein assay, and equal amounts of
protein were electrophoresed on a 10% Bis–Tris polyacrylamide
minigel (Invitrogen). PAb416 (1:200) (Genetex) in 5% non-fat dry
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and Actin (C-11)-R sc-1615-R (1:1000)(Santa Cruz Biotechnology) in
1% BSA/TBS-T for actin expression. After washing in PBS/TBS-T, blots
were probed with a horseradish peroxidase-conjugated secondary
antibody (1:10,000) (Promega). Antibody complexes were detected
using SuperSignal West Pico Chemiluminescent substrate (Thermo
scientiﬁc) and exposed to ﬁlm (Kodak).
RNA isolation and real-time RT-PCR ampliﬁcation
Total RNA was extracted using TRizol (Invitrogen) as described by
the manufacturer. Contaminating DNAs were removed by use of RQ1
DNase kit (Promega) as described by the manufacturer. cDNA was
generated using 20 μg RNA, random primers and the SuperScript™ II
Reverse Transcriptase (RT) Kit (Invitrogen) as described by the
manufacturer. A non-RT enzyme reaction was performed for each
sample as a negative control for cDNA synthesis. cDNA was then
subjected to real-time PCR analysis using Roche LightCycler 480 Syber
Green I Master Mix as a detector in the Roche Light Cycler 480.
Previously published primers for T Ag (Dana et al., 2005) and VP1
(Ding et al., 2002)were used. Gene expression valueswere normalized
to the levels of β-actin transcripts, using the 2−C(T) method, and are
presented as the changes (n-fold) in T Ag and VP1 transcript levels,
with the levels in uninfected/mock samples arbitrarily set to 1.
Encapsidated viral genome assay
The detection of infectious virus being released from HSG cells
was performed on HSG cell supernatant collected at stated times
post-infection. Supernatant was passed through a 0.45 µM ﬁlter and
DNase-treated or used to infect Vero cells as previously described
(Dugan et al., 2007). To degrade free DNA not encapsidated within
virions, supernatant was treated with 250 U DNase (Promega) or
water for 15 min at 56 °C, followed by enzyme inactivation at 65 °C
for 10 min. To release viral DNA (vDNA) from capsids, proteinase K
was used as described in the blood and body ﬂuid spin protocol of
the QIAamp DNA blood minikit (QIAGEN). DNA was eluted in 100 μl
of sterile water. Levels of viral DNA were determined using primers
for T Ag in real-time PCR as described above. A plasmid, pBKV
containing the entire genome of BKV, a gift from Volker Nickeleit
(UNC-CH) was used to derive standard curves for viral DNA
quantitation.
Virus puriﬁcation and labeling and confocal microscopy
BKV was propagated in Vero cells and puriﬁed as previously
described (Low et al., 2006). Brieﬂy, viral lysates, including all cell
debris, were adjusted to pH 7.4 with 0.5 M HEPES (pH 8.0) and
centrifuged at 8000×g for 30min at 4 °C. The supernatantwas removed,
and the pellet was resuspended in 5 ml of buffer A (10 mM HEPES [pH
7.9], 1mMCaCl2, 1mMMgCl2, and 5mMKCl). The pH of the lysate was
then adjusted to 6.0 with 0.5 M HEPES (pH 5.4), and 5 units of type V
neuraminidase (Sigma) was added and incubated for 1 h at 25 °C. The
solution was returned to pH 7.4 through the addition of 0.5 M HEPES
(pH8.0) and thenheated to 40°C and centrifuged at 16,000×g for 5min.
The supernatant was removed and saved, while the pellet was further
incubatedwith 5ml of buffer A containing 0.1% deoxycholate at 25°C for
15 min and then centrifuged at 16,000 ×g for 5 min. The supernatant
was removed, combinedwith theprevious supernatant, and centrifuged
through a 15% sucrose cushion into 35 g/100ml CsCl at 141,000 ×g in a
Beckman Optima LE-80K ultracentrifuge using a Beckman tube (28 by
89mm) in a Beckman SW28 rotor for 3.5 h at 20 °C. Virus was dialyzed
against buffer A, and titers were determined using the hemmaglutina-
tion assay and DNase protection assay.
Puriﬁed BKV was then labeled using Alexa-Fluor 488 microscale
protein labeling kit (Molecular Probes) as directed by the manufac-turer (bovine serum albumin (BSA) and 1× PBS were used as positive
and negative labeling controls). Brieﬂy, 100 μl of puriﬁed viral solution
or 1 mg/ml BSA or 100 μl 1× PBS was transferred to a reaction tube
and 10 μl of 1 M sodium bicarbonate added, 33 nmol Alexa-Fluor
tetraﬂuorophenyl ester was added and the reaction mixture was
incubated for 15 min. After incubation, 50 μl of the conjugate reaction
mixture was layered on the resin bed in the microcentrifuge tube and
centrifuged at 16,000 ×g for 1 min. The eluted virus was then used to
infect HSG or Vero cells in poly-L lysine coated 8-well chamber slides
(Falcon). At 24 and 48 hpi, monolayers of cells were ﬁxed with 50%
methanol/50% acetone for 10 min followed by addition of TO-PRO3
(Invitrogen) reagent at 1:10,000 for 2 min to stain the cell nucleus.
Cells were thenwashed and stored in 1× PBS and used to detect virion
entry using an Olympus FV 500 microscope.
Electron microscopy
HSG cells were infected with BKV or media (mock) and at 5 dpi the
cells were washed with 1× PBS and the cell monolayers ﬁxed with 3%
glutaraldehyde in 0.15 M sodium phosphate buffer. Cells were then
post-ﬁxed with potassium ferrocyanide-reduced osmium tetroxide.
Cells were embedded in situ in Polybed 812 epoxy resin and cut into
ultrathin sections of 70 nm. Sections were post-stained in uranyl
acetate and lead citrate then photographed using a LEO EM-910
transmission electron microscope (LEO Electron Microscopy Inc.
Thornwood, NY) with Orius camera at 80 kV. All sections were cut
parallel to the substrate.
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